EMC Capital Management’s United Therapeutics UTHR Stock Holding History

EMC Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$270K	Sell	555 -98	-15%	-$45.6K	0.12%	43
2025 Q3	$274K	Hold	653	–	–	0.13%	55
2025 Q2	$188K	Sell	653 -924	-59%	-$276K	0.1%	85
2025 Q1	$486K	Hold	1,577	–	–	0.29%	36
2024 Q4	$556K	Buy	1,577 +137	+10%	+$50.4K	0.31%	29
2024 Q3	$107K	Sell	1,440 -137	-9%	-$46.3K	0.07%	223
2024 Q2	$502K	Hold	1,577	–	–	0.29%	36
2024 Q1	$362K	Sell	1,577 -935	-37%	-$211K	0.22%	78
2023 Q4	$552K	Hold	2,512	–	–	0.37%	21
2023 Q3	$567K	Sell	2,512 -1,672	-40%	-$385K	0.42%	22
2023 Q2	$111K	Buy	4,184 +1,672	+67%	+$370K	0.09%	204
2023 Q1	$563K	Hold	2,512	–	–	0.47%	12
2022 Q4	$699K	Buy	2,512 +144	+6%	+$36.4K	0.63%	9
2022 Q3	$496K	Hold	2,368	–	–	0.46%	14
2022 Q2	$558K	Buy	2,368 +794	+50%	+$161K	0.48%	16
2022 Q1	$279K	Buy	+1,574	New	+$300K	0.2%	66

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

EMC Capital Management's UTHR Position: Q4 2025 in Review

EMC Capital Management reduced its United Therapeutics (UTHR) stake by 15% in Q4 2025, selling an estimated $45.6K and leaving 555 shares worth $270K. The position accounts for 0.12% of the portfolio, ranked #43.

EMC Capital Management first reported a position in UTHR in Q1 2022 and has held it in 16 quarters since. The position peaked at $699K in Q4 2022. 838 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

EMC Capital Management held 555 shares of United Therapeutics worth $270K as of Q4 2025.
EMC Capital Management sold 98 United Therapeutics shares in Q4 2025, an estimated $45.6K.
United Therapeutics made up 0.12% of EMC Capital Management's portfolio in Q4 2025, its #43 holding.
EMC Capital Management first reported a position in United Therapeutics in Q1 2022 and has held it in 16 quarters since.
EMC Capital Management's United Therapeutics position peaked at $699K in Q4 2022.
838 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on EMC Capital Management's 13F filing for Q4 2025, filed 9 Mar 2026.